March 18, 2021 12:13 PM EDTUpdated 02:29 PM
FDA+
Coronavirus

EMA calls for As­traZeneca vac­ci­na­tions to con­tin­ue af­ter safe­ty scares de­layed roll­out

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency (EMA) said Thurs­day that the use of As­traZeneca’s vac­cine should con­tin­ue as new de­tails emerge of some of the cas­es that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times